Clinical Trial Update: An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend [Phase 1, Phase 2]

View source ↗

Summary

This open-label study assessed pharmacokinetics and safety of multiple doses of Vfend (voriconazole) in patients with kidney failure. The study status was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure

Drugs mentioned

• VFEND (Voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Kidney Failure | Phase 1, Phase 2 | Status: TERMINATED